{"symbol": "KTOV", "companyName": "Kitov Pharma Ltd.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.kitovpharma.com", "description": "Kitov Pharma Ltd is engaged in the development of a combination drug that aims to treat osteoarthritis (OA) pain and hypertension called KIT-302 and NT219.", "CEO": "Isaac Israel", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}